Journal article
Stem Cell Transplantation for Light Chain Amyloidosis: Decreased Early Mortality Over Time.
Abstract
Purpose Autologous stem-cell transplantation (ASCT) has been used in patients with immunoglobulin light chain (AL) amyloidosis for more than two decades. Early experience raised concerns regarding safety with high early-mortality rates. Patients and Methods We report 20 years of experience with ASCT for AL amyloidosis at the Mayo Clinic Rochester. In all, 672 consecutive patients receiving ASCT for AL amyloidosis were divided into three cohorts …
Authors
Sidiqi MH; Aljama MA; Buadi FK; Warsame RM; Lacy MQ; Dispenzieri A; Dingli D; Gonsalves WI; Kumar S; Kapoor P
Journal
Journal of Clinical Oncology, Vol. 36, No. 13, pp. 1323–1329
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 1, 2018
DOI
10.1200/jco.2017.76.9554
ISSN
0732-183X